INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Optimizing clinical supply flexibility]( "Optimizing Clinical Supply Flexibility With Demand-Led Strategies")
Optimizing Clinical Supply Flexibility With Demand-Led StrategiesExplore demand-led supply strategies for clinical trials. Compare traditional vs. DLS models and learn when pack-to-order, pack-to-stock, or hybrid approaches optimize supply flexibility.
-
![GettyImages-1256602998-psychedelic-mindfulness]( "Unveiling The Potential Of Psychedelic Therapies")
Unveiling The Potential Of Psychedelic TherapiesLeading experts highlight the transformative potential of the rapidly evolving field of psychedelic therapies and underscore the importance of rigorous clinical trials and regulatory compliance.
-
![GettyImages-1068004492 women]( "Decentralized And Community-Based Solutions Driving Women's Healthcare")
Decentralized And Community-Based Solutions Driving Women's HealthcareClinical trials should reflect the affected population by reducing participation barriers and bringing trials to patients to increase inclusion and improve real-world data.
-
![Strategies For Research Institutions In An Evolving Era Of Oncology]( "Strategies For Research Institutions In An Evolving Era Of Oncology")
Strategies For Research Institutions In An Evolving Era Of OncologyAs biomarker-directed therapies drive advancements in the oncology space, experts are reviewing cutting-edge trends and strategies that help institutions address ethical and regulatory challenges.
-
10 Ways To Elevate Your Investigators' Meeting6/26/2024
Learn how you can take your next Investigators' Meeting from every day to exceptional with 10 top tips from the clinical meeting planning experts at Scout.
-
Avoiding Vaporware – Even More Questions To Ask eClinical Platform Providers8/7/2024
For a platform that aligns with the demands of modern clinical research, delve into these considerations to ensure your choice supports your study’s success.
-
The Final DCT Guidance: I'm Not Mad At It12/13/2024
Explore the FDA's 2024 final guidance on DCTs, including key updates that address previous concerns, affecting healthcare providers, sub-investigators, and sponsors.
-
Tips And Tricks For Developing Rare Cancer Clinical Trials2/6/2025
Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.
-
Top Approach To High Volume Enrollment In Clinical Research9/22/2025
Integrating technology with personalized support can ethically, efficiently, and transparently scale patient recruitment, ultimately improving trial outcomes and advancing translational research.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1288978528 Scientist Using Microscope In Lab]( "Drug Development Experience For Biotechs")
Leverage our extensive expertise across over 120 therapeutic indications to drive your success.
-
![Patient Satisfaction survey-GettyImages-1356228571]( "Elevating Success: The Crucial Role Of Customer Satisfaction Programs In Companies")
By examining how satisfaction data is gathered, interpreted, and acted upon, we highlight a framework intended to strengthen relationships and enhance service quality.
-
![GettyImages-1903972230 Sustainability Concept, Green Forest With Globe Earth]( "ecoScout For Meetings")
Discover Scout's strategies for elevated, eco-friendly face-to-face and hybrid events. ecoScout for Meetings takes a comprehensive approach to minimizing carbon emissions and maintaining the highest standards of quality and service.
-
![GettyImages-1174677845-blood work-blood tubes]( "Precision Kitting: Every Sample Matters, Every Detail Counts")
Precision starts at collection. The integrity of trial data depends on accurate, compliant, and traceable sample handling, but standard kitting isn’t built for the demands of biomarker-driven research.
-
![Clinicians doctors meeting iStock-1264556832]( "Think Bold. Think Scientific. Think Veristat.")
Veristat harnesses knowledge, expertise, and scale to provide superior solutions and progressive approaches to mitigate risks and achieve meaningful outcomes for biopharmaceutical and medical technology companies, and their patients.
